Nabilone. A preliminary review of its pharmacological properties and therapeutic use.

Author: HolmesB, WardA

Paper Details 
Original Abstract of the Article :
Nabilone is a new orally active cannabinoid for the treatment of severe gastrointestinal toxicity associated with cancer chemotherapy. The pharmacological profile of nabilone suggests that it acts primarily by preventing emesis controlled by the medulla oblongata, although its secondary mild anxioly...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00003495-198530020-00002

データ提供:米国国立医学図書館(NLM)

Nabilone: A New Hope for Managing Chemotherapy-Induced Nausea and Vomiting

This study examines the potential of [nabilone], a [cannabinoid] medication, for the management of [chemotherapy-induced nausea and vomiting]. The researchers conducted a review of the pharmacological properties and therapeutic applications of [nabilone], summarizing the available evidence on its effectiveness and side effects. Their findings highlight the potential of [nabilone] as a valuable treatment option for [severe gastrointestinal toxicity] associated with [cancer chemotherapy].

Nabilone: A Potential Solution for Chemotherapy-Induced Nausea and Vomiting

The study suggests that [nabilone] may offer a promising alternative for patients experiencing [severe nausea and vomiting] related to [chemotherapy]. The authors emphasize the importance of further research to compare [nabilone] with other antiemetic agents and evaluate its effectiveness in combination therapies.

Managing Chemotherapy Side Effects: Improving Patient Quality of Life

This research offers a glimmer of hope for patients undergoing [cancer chemotherapy]. The findings suggest that [nabilone] may play a role in mitigating [chemotherapy-induced nausea and vomiting], improving patient comfort and quality of life during treatment.

Dr. Camel's Conclusion

This study is like a desert oasis offering respite from the harsh realities of [chemotherapy-induced nausea and vomiting]. The authors explore the potential of [nabilone], a [cannabinoid] medication, to alleviate these debilitating side effects. This research underscores the importance of finding new and effective ways to manage the challenges associated with cancer treatment.

Date :
  1. Date Completed 1985-10-16
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

2863127

DOI: Digital Object Identifier

10.2165/00003495-198530020-00002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.